A Randomized, Placebo-controlled, Within-device, Double-blind Tri-national Study to Compare the Safety and Efficacy of Berodual® Administered Via the Respimat® Device (50 µg Fenoterol Hydrobromide/20 µg Ipratropium Bromide and 25 µg Fenoterol Hydrobromide/10 µg Ipratropium Bromide, 1 Puff q.i.d) With That Administered Via the MDI (50 µg Fenoterol Hydrobromide/21 µg Ipratropium Bromide, 2 Puffs q.i.d) in COPD Patients Over a 12-week Period

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02173782

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:40.182986+00:00

Published At

2014-07-14T00:00:00+00:00

Record Updated At

2014-07-14

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pulmonary Disease, Chronic Obstructive"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-07-14"

protocolSection.identificationModule.nctId

"NCT02173782"

protocolSection.identificationModule.officialTitle

"A Randomized, Placebo-controlled, Within-device, Double-blind Tri-national Study to Compare the Safety and Efficacy of Berodual\u00ae Administered Via the Respimat\u00ae Device (50 \u00b5g Fenoterol Hydrobromide/20 \u00b5g Ipratropium Bromide and 25 \u00b5g Fenoterol Hydrobromide/10 \u00b5g Ipratropium Bromide, 1 Puff q.i.d) With That Administered Via the MDI (50 \u00b5g Fenoterol Hydrobromide/21 \u00b5g Ipratropium Bromide, 2 Puffs q.i.d) in COPD Patients Over a 12-week Period"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Pulmonary Disease, Chronic Obstructive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.